IDEA-FAST 2023 General Assembly

We are excited to announce that the IDEA-FAST 2023 General Assembly was a great success! The event was held in Barcelona on 16 and 17 March, with attendance of 100 consortium members from 40 organizations, both in person and online, including 7 attendees from the clinical sites. The meeting included plenary and breakout sessions that enabled us to review the project’s progress and future requirements, identify new growth opportunities, and strengthen communication among consortium members.

The assembly also featured a poster session with 17 participants, during which consortium members presented their posters, and attendees voted on their favourite. We are delighted to congratulate the winners of our poster sessions:

  • Johanna Graeber with a poster titled “Technology Acceptance of digital devices. A qualitative sub study of the IDEA-FAST Feasibility Study” secured the first place.
  • Clémence Pinaud with a poster titled “Overview of the Statistical Analysis Plan of the IDEA-FAST Clinical Observational Study” was awarded the second place.
  • Adrien Bennetot with a poster titled “Investigating patient-reported fatigue in immune-mediated inflammatory disorders and neurodegenerative diseases” came in third place.

The poster session was a highlight of the assembly, and we congratulate all of the winners and participants for their outstanding contributions.

In addition to the Work Package Meetings and progress updates, we included sessions of COS study site meetings, to discuss the challenges that have come up so far during patient recruitment and to identify mitigation strategies and solutions to any current or foreseen impediments.

Despite the challenges posed by COVID-19, we are proud to report that IDEA-FAST has continued to make significant progress in advancing the Clinical Observational Study (COS) recruitment process, digital technology, and data analysis. We remain committed to accelerating our activities over the next few months, including participant recruitment, improving COS data quality, and maintaining our patient and public engagement.

We are excited about the progress we have made so far, and we look forward to continuing our efforts to advance towards achieving the goals of the IDEA-FAST project.